Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 1997

View Archived Issues

SKB discloses improved antihyperlipidemic agent

Improved immunomodulating agent described by SKB

Antifungal agents from Nihon Nohyaku

Alcon prepares carbonic anhydrase inhibitors

Antiestrogenics from Schering AG

Boehringer Mannheim reports new antiplatelet agents

Somatostatin receptor antagonists prepared by Novartis

Small, specific inhibitors of VLA4-mediated cell adhesion from Biogen

Antiherpesvirus agent from Roche

Guilford reports 1996 year-end results

NeuroSearch profit announcement in 1996

Neurogen reports 1996 financial results

Genzyme Transgenics reports record fourth-quarter revenues

Genelabs Technologies reports 1996 fourth-quarter and year-end results

Long-acting injectable antifungal enters phase II trials

SS Pharm./Torii developing new antiallergic agent

Zeria and Lilly seek OTC switch for Asinon

Antiparkinson Rx from Sumitomo in pivotal European trials

Pharma Mar product update

Fluticasone associated with more adrenal suppression than budesonide

Cortecs signs oral delivery R&D agreement

Biosite Diagnostics licenses Scios technology

Matrix's radiation enhancer enters phase I/II

Clinical trial results for Neuprex in hepatectomy and meningococcemia

First live oral cholera vaccine approved in Canada

Pharmacopeia achieves milestone in collaboration with Schering-Plough

Banner Pharmacaps granted rights to softgel drug delivery system

Aastrom CPS enters clinical trials in Europe

Neugenesis granted patent for combinatorial biology platform

Visible Genetics and Consolidated Laboratory Services develop HIV tests

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...